Which cholesterol medicine combo works better?

Original Title

Safety and efficacy of moderate-intensity statin plus ezetimibe versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease: A meta-analysis.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

The study looks at two ways to treat high cholesterol in heart disease patients: one uses a strong statin alone, the other uses a medium-strength statin with another drug called ezetimibe.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

A moderate-dose statin combo outperformed a high-dose statin in lowering cholesterol, despite the latter being the current standard of care.

Doctors often assume stronger statins work better—this challenges that idea by showing a combo approach may be superior even with a lower statin dose.

Practical Takeaways

Patients with atherosclerotic cardiovascular disease who aren’t reaching their LDL-C goal on a high-intensity statin might benefit from switching to or adding ezetimibe to a moderate-intensity statin.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

39%
Lower QualityOverall Score

Publication

Journal

Journal of clinical lipidology

Year

2024

Authors

F. Kelly, F. C. A. de Moraes, A. Lôbo, V. M. Siebel, M. Leite, A. D. de Almeida, F. Consolim-Colombo

Open Access
10 citations
Analysis v1